0001209191-15-078180.txt : 20151103 0001209191-15-078180.hdr.sgml : 20151103 20151103180457 ACCESSION NUMBER: 0001209191-15-078180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151030 FILED AS OF DATE: 20151103 DATE AS OF CHANGE: 20151103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 151194898 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-10-30 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Policy, Access & Value Common Stock 2015-10-30 4 S 0 700 123.34 D 84201 D Common Stock 2015-10-30 4 S 0 1500 124.94 D 82701 D Common Stock 2015-10-30 4 S 0 2638 126.01 D 80063 D Common Stock 2015-10-30 4 S 0 1100 126.61 D 78963 D Common Stock 882 I 401(k) Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $123.34 (range $123.06 to $123.66). Open market sales reported on this line occurred at a weighted average price of $124.94 (range $124.40 to $125.37). Open market sales reported on this line occurred at a weighted average price of $126.01 (range $125.43 to $126.39). Open market sales reported on this line occurred at a weighted average price of $126.61 (range $126.44 to $126.75). Omar White, Attorney-In-Fact 2015-11-03